Skip to main content
PMC home page
Journal of Cellular and Molecular Medicine logoLink to Journal of Cellular and Molecular Medicine
. 2007 May 1;7(3):265–276. doi: 10.1111/j.1582-4934.2003.tb00227.x

Catalytic antibodies in healthy humans and patients with autoimmune and viral diseases

G A Nevinsky 1,✉, Valentina N Buneva 1
PMCID: PMC6741318  PMID: 14594551

Abstract

Antibodies have been first characterized as proteins produced by the immune system solely for binding other molecules, called antigens, with the goal of eliciting immune response. In this classical conception, antibodies act similarly to enzymes in specific binding to different molecules but cannot catalyze their chemical conversion. However, in 1986 the first monoclonal catalytic antibodies against a chemically stable analog of the transition state of a reaction were obtained and termed abzymes (Abzs). At present, artificial monoclonal Abzs catalyzing more than 100 distinct chemical reactions have been obtained. The discovery of IgG specifically hydrolyzing intestinal vasoactive peptide in the blood serum of asthma patients stimulated studies of natural Abzs. Numerous Abzs discovered afterwards in sera of patients with various autoimmune diseases, viral disorders, or in the milk of healthy mothers, are capable of hydrolyzing proteins, DNA, RNA, polysaccharides, or nucleotides, as well as to phosphorylate proteins and lipids. The phenomenon of catalysis by auto‐Abzs is more and more in research focus. In this review we summarize new data on Abzs applications in basic science, medicine and biotechnology.

Keywords: abzymes, autoimmune and viral disorder, medicine, biotechnology

References

  • 1. Pauling L., Molecular basis of biological specificity, Am. Sci., 36: 51–59, 1946. [DOI] [PubMed] [Google Scholar]
  • 2. Jencks W., Catalysis in Chemistry and Enzymology, McGraw‐Hill, N.Y. , 1969. [Google Scholar]
  • 3. Slobin L.I., Preparation and some properties of antibodies with specificity toward ortho‐nitrophenyl esters, Biochemistry, 5: 2836–2841, 1966. [DOI] [PubMed] [Google Scholar]
  • 4. Schochetman G., Massey R., International Patent no. W085/02414, 1985.
  • 5. Pollack S.J., Jacobs J.W., Schultz P.G. Selective chemical catalysis by an antibody, Science, 234: 1570–1573, 1986. [DOI] [PubMed] [Google Scholar]
  • 6. Tramontano A., Janda K.D., Lerner R.A., Catalytic antibodies, Science, 234: 1566–1570, 1986. [DOI] [PubMed] [Google Scholar]
  • 7. Paul S., Volle D.J., Beach C.M., Johnson D.R., Powell M.J., Massey R.J., Catalytic hydrolysis of vasoactive intestinal peptide by human autoantibody, Science, 244: 1158–1162, 1989. [DOI] [PubMed] [Google Scholar]
  • 8. Schultz P.G., Lerner R.A., From molecular diversity to catalysis: lessons from the immune system, Science, 269: 1835–1840, 1995. [DOI] [PubMed] [Google Scholar]
  • 9. Suzuki H., Recent advances in abzyme studies, J. Biochem. (Tokyo), 115: 623–628, 1994. [DOI] [PubMed] [Google Scholar]
  • 10. Nevinsky G.A., Semenov D.V., Buneva V.N., Catalytic antibodies (abzymes) induced by stable transition‐state analogs. Biochemistry (Moscow), 65: 1233–1244, 2000. [PubMed] [Google Scholar]
  • 11. Nevinsky G.A., Favorova O.O., Buneva V.N., Catalytic antibodies: New characters in the protein repertoire In: Golemis E., eds., Protein‐protein interactions. A molecular cloning manual, Cold Spring Harbor Lab. Press, Cold Spring Harbor , New York , 2002, pp. 523–534. [Google Scholar]
  • 12. Shuster A.M., Gololobov G.V., Kvashuk O.A., Bogomolova A.E., Smirnov I.V., Gabibov A.G., DNA hydrolyzing autoantibodies, Science, 256: 665–667, 1992. [DOI] [PubMed] [Google Scholar]
  • 13. Buneva V.N., Andrievskaia O.A., Romannikova I.V., Gololobov G.V., Iadav R.P., Iamkovoi V.I., Nevinskii G.A., Interaction of catalytically active antibodies with oligoribonucleotides. Mol. Biol. (Moscow), 28: 738–743, 1994. [PubMed] [Google Scholar]
  • 14. Nevinsky G.A., Kanyshkova T.G., Buneva V.N., Natural catalytic antibodies (abzymes) in normalcy and pathology, Biochemistry (Moscow), 65: 1245–1255, 2000. [PubMed] [Google Scholar]
  • 15. Nevinsky G.A., Buneva V.N., Human catalytic RNA‐ and DNA‐hydrolyzing antibodies. J. Immunol. Methods, 269: 235–249, 2002. [DOI] [PubMed] [Google Scholar]
  • 16. Nevinsky GA, Buneva VN. Natural catalytic antibodies ‐abzymes In: Keinan Ehud, eds., Catalytic antibodies, VCH‐Wiley press, 2003, in press. [PubMed] [Google Scholar]
  • 17. Baranovsky, A.G. , Matushin V.G., Vlassov A.V., Zabara V.G., Naumov V.A., Buneva, V.N. , Nevinsky G.A., DNA‐ and RNA‐hydrolyzing antibodies from the blood of patients with various forms of viral hepatitis, Biochemistry (Moscow)., 62: 1358–1366, 1997. [PubMed] [Google Scholar]
  • 18. Vlassov A.V., Baranovskii A.G., Kanyshkova T.G., Prints A.V., Zabara V.G., Naumov V.A., Breusov A.A., Buneva V.N., Nevinsky G.A., Substrate specificity of DNA‐ and RNA‐hydrolyzing antibodies from blood of patients with polyarthritis and Hashimoto's thyroiditis. Mol. Biol. (Moscow), 32: 559–569, 1998. [PubMed] [Google Scholar]
  • 19. Baranovskii A.G., Kanyshkova T.G., Mogelnitskii A.S., Naumov V.A., Buneva V.N., Gusev E.I., Boiko A.N., Zargarova T.A., Favorova O.O., Nevinsky G.A., Polyclonal antibodies from blood and cerebrospinal fluid of patients with multiple sclerosis effectively hydrolyze DNA and RNA. Biochemistry (Moscow), 63: 1239–1248, 1998. [PubMed] [Google Scholar]
  • 20. Li L., Paul S., Tyutyulkova S., Kazatchkine M.D., Kaveri S., Catalytic activity of antithyroglobulin antibodies. J Immunol., 154: 3328–3332, 1995. [PubMed] [Google Scholar]
  • 21. Paul S., Li L., Kalaga R., O'Dell J., Dannenbring R.E., Swindells Jr., Hinrichs S., Caturegli P., Rose N.R., Characterization of thyroglobulin‐directed and polyreactive catalytic antibodies in autoimmune disease, J Immunol., 159: 1530–1536, 1997. [PubMed] [Google Scholar]
  • 22. Thiagarajan P., Dannenbring R., Matsuura K., Tramontano A., Gololobov G., Paul S., Monoclonal antibody light chain with prothrombinase activity, Biochemistry, 39: 6459–6465, 2000. [DOI] [PubMed] [Google Scholar]
  • 23. Lacroix‐Desmazes S., Moreau A., Sooryanarayana A., Bonnemain C., Stieltjes N., Pashov A., Sultan Y., Hoebeke J., Kazatchkine M.D., Kaveri S.V., Catalytic activity of antibodies against factor VIII in patients with hemophilia A. Nat Med., 5: 1044–1047, 1999. [DOI] [PubMed] [Google Scholar]
  • 24. Saveliev A.N., Ivanen D.R., Kulminskaya A.A., Ershova N.A., Kanyshkova T.G., Buneva V.N., Mogelnitskii A.S., Doronin B.M., Favorova O.O., Nevinsky G.A., Neustroev K.N., Amylolytic activity of IgM and IgG antibodies from patients with multiple sclerosis. Immunol Lett., 86: 291–297, 2003. [DOI] [PubMed] [Google Scholar]
  • 25. Kanyshkova T.G., Semenov D.V., Khlimankov D.Yu., Buneva V.N., Nevinsky G.A., DNA ‐hydrolyzing activity of the light chain of IgG antibodies from milk of healthy human mothers, FEBS Lett., 416: 23–26, 1997. [DOI] [PubMed] [Google Scholar]
  • 26. Buneva V.N., Kanyshkova T.G., Vlassov A.V., Semenov D.V., Khlimankov D., Breusova L.R., Nevinsky G.A., Catalytic DNA‐ and RNA‐hydrolyzing antibodies from milk of healthy human mothers, Appl. Biochem. Biotechnol., 75: 63–76, 1998. [DOI] [PubMed] [Google Scholar]
  • 27. Nevinsky G.A., Kanyshkova T.G., Semenov D.V., Vlassov A.V., Gal'vita A.V., Buneva V.N., Secretory immunoglobulin A from healthy human mothers' milk catalyzes nucleic acid hydrolysis, Appl. Biochem. Biotechnol., 83: 115–129, 2000. [DOI] [PubMed] [Google Scholar]
  • 28. Savel'ev A.N., Kanyshkova T.G., Kulminskaya A.A., Buneva V.N., Eneyskaya E.V., Filatov M.V., Nevinsky G.A., Neustroev K.N., Amylolytic activity of IgG and sIgA immunoglobulins from human milk, Clin. Chim. Acta., 314: 141–152, 2001. [DOI] [PubMed] [Google Scholar]
  • 29. Semenov D.V., Kanyshkova T.G., Kit Y.Y., Khlimankov D.Y., Akimzhanov A.M., Gorbunov D.A., Buneva V.N., Nevinsky G.A., Human breast milk immunoglobulins G hydrolyze nucleotides, Biochemistry (Moscow), 63: 935–943, 1998. [PubMed] [Google Scholar]
  • 30. Nevinsky G.A., Kit Y., Semenov D.V., Khlimankov D., Buneva V.N., Secretory immunoglobulin A from human milk catalyzes milk protein phosphorylation, Appl. Biochem. Biotechnol., 75: 77–91, 1998. [DOI] [PubMed] [Google Scholar]
  • 31. Gorbunov D.V., Semenov D.V., Shipitsin M.V., Kit Y.Y., Kanyshkova T.G., Buneva V.N., Nevinsky G.A., Phosphorylation of minor lipids of human milk tightly bound to secretory immunoglobulin A, Russ. J. Immunol., 5: 267–278, 2000. [PubMed] [Google Scholar]
  • 32. Kul'berg A.I, Docheva I.V., Tarkhanova I.A., Spivak V.A., Proteolytic activity in preparations of purified immunoglobulin G and rabbit antibodies, Biokhimiia (Moscow), 34: 1178–1183, 1969. [PubMed] [Google Scholar]
  • 33. Wentworth A.D., Jones L.H., Wentworth P.Jr., Janda, K.D. , Lerner, R.A. , Antibodies have the intrinsic capacity to destroy antigens, Proc. Natl. Acad. Sci. USA, 97: 10930–10935, 2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Wentworth P. Jr., Jones L.H., Wentworth A.D., Zhu X., Larsen N.A., Wilson I.A., Xu X., Goddard W.A., Janda, K.D. , Eschenmoser A., Lerner R.A., Antibody catalysis of the oxidation of water, Science, 293: 1806–1811, 2001. [DOI] [PubMed] [Google Scholar]
  • 35. Luo G.M., Qi D.H., Zheng Y.G., Mu Y., Yan G.L., Yang T.S., Shen J.C., ESR studies on reaction of saccharide with the free radicals generated from the xanthine oxidase/hypoxanthine system containing iron, FEBS Lett., 492: 29–32, 2001. [DOI] [PubMed] [Google Scholar]
  • 36. Generalov II, Novikov DK, Zhiltsov IV, Catakytic antibodies, Vestsi Natsyyanal'nai Akademii Navuk Belarusi, Seryya Biyalagichnykh Navuk 1: 90–96, 1999. [Google Scholar]
  • 37. Boiko A.N., Favorova O.O., Multiple sclerosis: molecular and cellular mechanisms. Mol Biol (Mosk), 29: 727–749, 1995. [PubMed] [Google Scholar]
  • 38. Earnshaw W.C., Rothfield N., Identification of a family of human centromere proteins using autoimmune sera from patients with scleroderma, Chromosoma, 91: 313–321, 1985. [DOI] [PubMed] [Google Scholar]
  • 39. Reimer C., Raska I., Tan E.M., Sheer U., Human autoantibodies: probes for nucleolus structure and function, Virchows Arch. B Cell. Pathol. Incl. Mol. Pathol, 54: 131–143, 1987. [DOI] [PubMed] [Google Scholar]
  • 40. Jerne N.K., Towards a network theory of the immune system. Ann Immunol, 125: 373–389, 1974. [PubMed] [Google Scholar]
  • 41. Izadyar L., Friboulet A., Remy M.H., Roseto A., Thomas D., Monoclonal anti‐idiotypic antibodies as functional internal; images of enzyme active sites: production of a catalytic antibody with a cholinesterase activity, Proc. Natl. Acad. Sci. USA 90, 8876–8880, 1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. Kolesnikov A.V., Kozyr A.V., Alexandrova E.S., Koralewski F., Demin A.V., Titov M.I., Avalle B., Tramontano A., Paul S., Thomas D., Gabibov A.G., Friboulet A., Enzyme mimicry by the antiidyotypic antibody approach, Proc. Natl. Acad. Sci. USA, 97: 13526–13531, 2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Crespeau H., Laouar A., Rochu D., C. R. Acad. Sci. III, 317: 819–23, 1994. [PubMed] [Google Scholar]
  • 44. Buneva V.N., Kudryavtseva A.N., Gal'vita A.V., Dubrovskaya V.V., Khokhlova O.V., Kalinina, I.A. , Galenok V.A., Nevinsky G.A., Dynamics of nuclease activity level from blood of pregnant and patrturient women, Biochemistry (Moscow), 2003, in press. [DOI] [PubMed] [Google Scholar]
  • 45. Bronshtein I.B., Shuster A.M., Gololobov G.V., Gromova I.I., Kvashuk O.A., Belostotskaya K.M., Alekberova Z.S., Prokaeva T.B., Gabibov A.G., DNAspecific antiidyotypic antibodies in the sera of patients with autoimmune diseases, FEBS Lett., 314: 259–264, 1992. [DOI] [PubMed] [Google Scholar]
  • 46. Andrievskaia O.A., Kanyshkova T.G., Iamkovoi V.I., Buneva V.N., Nevinskii G.A., Monoclonal antibodies to DNA hydrolyze RNA better than DNA, Dokl. Akad. Nauk (Moscow), 355: 401–403, 1997. [PubMed] [Google Scholar]
  • 47. Vlassov A., Florentz C., Helm M., Naumov V., Buneva V., Nevinsky G., Giege R., Characterization and selectivity of catalytic antibodies from human serum with RNase activity, Nucl. Acid Research, 26: 5243–5250, 1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48. Vlasov A.V., Helm M., Naumov V.A., Breusov A.A., Buneva V.N., Florentz C., Giege R., Nevinskii G.A., Features of tRNA hydrolysis by autoantibodies from blood serum of patients with certain autoimmune and virus diseases. Mol. Biol. (Moscow), 33: 866–872, 1999. [PubMed] [Google Scholar]
  • 49. Vlassov A.V., Helm M., Florentz C., Naumov V., Dreusov A.A. Buneva V., Giege R., Nevinsky G.A. Variability of substrate specificity of serum antibodies obtained from patients with different autoimmune and viral deseases in reaction of tRNA hydrolysis, Rus. J. Immunol, 4, 25–32, 1999. [PubMed] [Google Scholar]
  • 50. Baranovskii A.G., Ershova N.A., Buneva V.N., Kanyshkova T.G., Mogelnitskii A.S., Doronin B.M., Boiko A.N., Gusev E.I., Favorova O.O., Nevinsky G.A., Catalytic heterogeneity of polyclonal DNA‐hydrolyzing antibodies from the sera of patients with multiple sclerosis. Immunol. Lett., 76: 163–167, 2001. [DOI] [PubMed] [Google Scholar]
  • 51. Andrievskaya O.A., Buneva V.N., Baranovskii A.G., Gal'vita A.V., Benzo E.S., Naumov V.A., Nevinsky G.A., Catalytic diversity of polyclonal RNA‐hydrolyzing IgG antibodies from the sera of patients with lupus erythematosus, Immunol. Lett., 81, 191–198, 2002. [DOI] [PubMed] [Google Scholar]
  • 52. Kozyr AV, Kolesnikov A., Aleksandrova ES, Sashchenko LP, Gnuchev N., Favorov PV, Kotelnikov MA, Iakhnina EI, Astsaturov IA, Prokaeva TB, Alekberova ZS, Suchkov SV, Gabibov AG, Novel functional activities of anti‐DNA autoantibodies from sera of patients with lymphoproliferative and autoimmune diseases. Appl Biochem Biotechnol, 75, 45–61, 1998. [DOI] [PubMed] [Google Scholar]
  • 53. Nevinsky G.A., Breusov A.A., Baranovskii A.G., Prints A.V., Kanyshkova T.G., Gal'vita A.V., Naumov V.A., Buneva V.N., Effect of different drugs on the level of DNA‐hydrolyzing polyclonal IgG antibodies in sera of patients with Hashimoto's thyroiditis and nontoxic nodal goiter. Med. Sci. Monit., 7: 201–211, 2001. [PubMed] [Google Scholar]
  • 54. De Prada P., Winger G., Landry D.W., Application of artificial enzymes to the problem of cocaine, Ann. N.Y. Acad. Sci, 909: 159–169, 2000. [DOI] [PubMed] [Google Scholar]
  • 55. Paul, S. , Kalaga R.S., Gololobov G., Brenneman D., Natural catalytic immunity is not restricted to autoantigenic substrates: identification of a human immunodeficiency virus gp 120‐cleaving antibody light chain, Appl. Biochem. Biotechnol., 83: 71–82, 2000. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Cellular and Molecular Medicine are provided here courtesy of Blackwell Publishing

RESOURCES